Quick Overview: The session will examine the acceleration of gene therapy A recording of Jett Foundation's live Community Solid Biosciences joined PPMD for a community

Webinar Asp0367 Development Program Update - Detailed Overview & Context

The session will examine the acceleration of gene therapy A recording of Jett Foundation's live Community Solid Biosciences joined PPMD for a community The U.S. Food & Drug Administration (FDA) holds a public meeting on April 6, 2017, to hear directly from patients, caregivers, and ... Explore the innovations that are shaping emerging therapies and MS research. In this With the recent historic accelerated approval of Exondys 51 and other potential therapies currently in review and in late stages of ...

Join us on May 11, 2026 at 12:00 PM – 1:00 PM ET for an ASPPH Presents 0:00 2:56 Introductions 4:55 Patients: Share Your Experiences with the FDA 5:42 The Basics: What is avacopan (Tavneos)? The session took place at 2:30 p.m. on Tuesday, Dec. 10. YOUTUBE CHAPTERS 0:00 Introduction by moderators Saranya ...

Photo Gallery

Webinar: ASP0367 Development Program Update (May 2021)
Community Webinar Series 2021: ASP0367 Development Program Update with Astellas
Community Webinar Series 2021: ASP0367 Development Program Update with Astellas
Clinical Trials Update: Astellas
Updates in Research and Care:  Mitochondrial Myopathy
In the Pipeline: Downstream Targets - Astellas Pharma
2023 EHA/ASCO Updates: MDS and AML
Accelerating Development Through Regulatory Flexibility: Evolving Endpoints in Gene Therapy
Community Webinar: Novel Approach to Protect Muscle in Duchenne and Becker from Edgewise
Webinar: Community Update on the New INSPIRE DUCHENNE Clinical Study of SGT-003
Webinar: Preparing for the Patient-Focused Drug Development Meeting on Sarcopenia
Emerging Therapies: Multiple Sclerosis Research Update December 2025
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored